TrialClinical and translational science2026
Population Pharmacokinetic, Exposure-Response Efficacy and Safety Analyses of Favezelimab in Patients With Solid Tumors.
Mitali Gaurav et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.